LS Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,065
| Closed | -$214K | – | 1141 |
|
|
2020
Q2 | $214K | Sell |
3,065
-130
| -4% | -$9.08K | 0.01% | 698 |
|
|
2020
Q1 | $145K | Hold |
3,195
| – | – | 0.01% | 756 |
|
|
2019
Q4 | $208K | Buy |
3,195
+938
| +42% | +$61.1K | 0.01% | 787 |
|
|
2019
Q3 | $140K | Sell |
2,257
-16
| -0.7% | -$992 | 0.01% | 937 |
|
|
2019
Q2 | $162K | Sell |
2,273
-258
| -10% | -$18.4K | 0.01% | 881 |
|
|
2019
Q1 | $198K | Sell |
2,531
-43
| -2% | -$3.36K | 0.01% | 803 |
|
|
2018
Q4 | $218K | Buy |
2,574
+381
| +17% | +$32.3K | 0.02% | 710 |
|
|
2018
Q3 | $376K | Sell |
2,193
-280
| -11% | -$48K | 0.02% | 600 |
|
|
2018
Q2 | $320K | Sell |
2,473
-20
| -0.8% | -$2.59K | 0.02% | 672 |
|
|
2018
Q1 | $257K | Sell |
2,493
-14
| -0.6% | -$1.44K | 0.02% | 743 |
|
|
2017
Q4 | $214K | Buy |
2,507
+183
| +8% | +$15.6K | 0.01% | 854 |
|
|
2017
Q3 | $197K | Buy |
2,324
+405
| +21% | +$34.3K | 0.01% | 929 |
|
|
2017
Q2 | $145K | Hold |
1,919
| – | – | 0.01% | 1008 |
|
|
2017
Q1 | $127K | Buy |
1,919
+579
| +43% | +$38.3K | 0.01% | 1041 |
|
|
2016
Q4 | $85K | Buy |
1,340
+62
| +5% | +$3.93K | 0.01% | 1096 |
|
|
2016
Q3 | $81K | Hold |
1,278
| – | – | 0.01% | 1071 |
|
|
2016
Q2 | $95K | Buy |
1,278
+121
| +10% | +$9K | 0.01% | 1014 |
|
|
2016
Q1 | $77K | Buy |
1,157
+67
| +6% | +$4.46K | 0.01% | 978 |
|
|
2015
Q4 | $74K | Hold |
1,090
| – | – | 0.01% | 985 |
|
|
2015
Q3 | $58K | Hold |
1,090
| – | – | ﹤0.01% | 1073 |
|
|
2015
Q2 | $69K | Buy |
+1,090
| New | +$69K | 0.01% | 1040 |
|